Ethypharm erweitert sein Mesalazin (Etiasa®) Portfolio in China ...Middle East

SAINT CLOUD, Frankreich, 14. Juni 2024 /PRNewswire/ -- Ethypharm freut sich, den Erwerb einer Zäpfchenform von Mesalazin durch seine chinesische Tochtergesellschaft, Shanghai Ethypharm Pharmaceuticals Ltd, von dem chinesischen Unternehmen Jiangsu Anbison Pharmaceutical bekannt zu geben....

Hence then, the article about ethypharm erweitert sein mesalazin etiasa portfolio in china was published today ( Friday 14/06/2024 - 02:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ethypharm erweitert sein Mesalazin (Etiasa®) Portfolio in China )

Also on site :

• Decorated local aviator details his pursuit of recognition for his fellow shadow warriors of the Cold War
• Karol G Stunned by Surprise AMAs Win After Accepting International Artist of Excellence: ‘My Life Is Meaningful Because of My Music’
• Katseye Brings the AMAs’ House Down With Beary Exciting ‘Pinky Up’ Performance, Before Winning Best New Artist